CPI receives £5m from UK govt for 'vaccine library'

UK innovation hub CPI has received a further £5 million ($7 million) investment from the UK government to support the development of new mRNA vaccines to protect against new variants of COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Under-pressure pharma groups release vaccine scale-up plan

25 May 2021 Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

Americas

Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal

3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

More on this story

Big Pharma

Under-pressure pharma groups release vaccine scale-up plan

25 May 2021 Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

Americas

Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal

3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.

More on this story

Big Pharma

Under-pressure pharma groups release vaccine scale-up plan

25 May 2021 Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.

Americas

Sanofi, GSK secure $2.1bn from US in COVID-19 vaccine deal

3 August 2020 The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.

Big Pharma

EC backs voluntary COVID-19 vaccine licensing

18 June 2020 The European Commission has backed voluntary IP licensing as part of its new vaccines strategy.